Castration Resistant Prostatic Neoplasms
Oncology·MeSH: Prostatic Neoplasms
Prevalence
256.0 / 100K
Incidence
111.0 / 100K/yr
0 drugs in development·0 companies·2 clinical trials
Frequently asked questions
How many clinical trials target Castration Resistant Prostatic Neoplasms?
There are 2 clinical trials targeting Castration Resistant Prostatic Neoplasms tracked by BioSniper.
What is the prevalence of Castration Resistant Prostatic Neoplasms?
The estimated prevalence of Castration Resistant Prostatic Neoplasms is approximately 256.0 per 100,000 population.
Deep-dive into Castration Resistant Prostatic Neoplasms
Full trial data, competitive analysis, and AI-powered pipeline tracking.
Start Free Analysis